Octreoscan


Indications and Reactions:

Role Indications Reactions
Primary
Somatostatin Receptor Scan 27.2%
Somatostatin Analogue Therapy 16.0%
Carcinoid Tumour Of The Gastrointestinal Tract 12.8%
Carcinoid Tumour 11.2%
Neuroendocrine Tumour 4.0%
Helicobacter Gastritis 3.2%
Anxiety 2.4%
Chemotherapy 2.4%
Glucagonoma 2.4%
Insulinoma 2.4%
Radioisotope Scan 2.4%
Thyroid Disorder 2.4%
Asthma 1.6%
Hypertension 1.6%
Migraine 1.6%
Neoplasm 1.6%
Scintigraphy 1.6%
Supplementation Therapy 1.6%
Blood Pressure Increased 0.8%
Gastrinoma 0.8%
Drug Ineffective 17.7%
Platelet Toxicity 11.3%
Intentional Drug Misuse 9.7%
White Blood Cell Disorder 9.7%
Platelet Disorder 8.1%
Nausea 4.8%
Neoplasm Progression 4.8%
Accidental Exposure 3.2%
Dizziness 3.2%
Feeling Abnormal 3.2%
Lymphopenia 3.2%
Pyrexia 3.2%
Skin Lesion 3.2%
Tachycardia 3.2%
Thrombocytopenia 3.2%
Blood Creatinine Increased 1.6%
Blood Pressure Increased 1.6%
Death 1.6%
Embolism 1.6%
False Positive Laboratory Result 1.6%
Secondary
Somatostatin Analogue Therapy 37.6%
Somatostatin Receptor Scan 20.3%
Carcinoid Tumour 18.3%
Carcinoid Tumour Of The Gastrointestinal Tract 10.9%
Insulinoma 4.5%
Glucagonoma 3.0%
Gastrinoma 1.5%
Neoplasm 1.0%
Neuroendocrine Tumour 1.0%
Chemotherapy 0.5%
Hypothyroidism 0.5%
Nausea 0.5%
Pain 0.5%
Platelet Toxicity 29.7%
White Blood Cell Disorder 16.5%
Thrombocytopenia 11.0%
Intentional Drug Misuse 9.9%
Platelet Disorder 8.8%
Nausea 5.5%
Lymphopenia 4.4%
Therapeutic Response Decreased 4.4%
Drug Ineffective 2.2%
Metastatic Pain 2.2%
Feeling Abnormal 1.1%
Off Label Use 1.1%
Red Blood Cell Count Decreased 1.1%
Therapeutic Agent Toxicity 1.1%
Wrong Drug Administered 1.1%

Drug Data